Jerrold R. Turner MD, PhDProfessor of Pathology and Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts
Dr. Jerrold Turner is a Professor of Pathology and Medicine at Brigham and Women’s Hospital and Harvard Medical School. He has an active practice as a gastrointestinal surgical pathologist and directs a dynamic research laboratory focused on epithelial cell biology, gastrointestinal physiology and disease, and drug development, with particular emphasis on tight junctions and transepithelial transport. Dr. Turner has held multiple leadership roles within the American Gastroenterological Association, including service as founding Editor-in-Chief of Cellular and Molecular Gastroenterology and Hepatology, American Physiological Society, and American Society for Investigative Pathology. Dr. Turner’s contributions have been recognized by election to membership in the American Society for Clinical Investigation and Association of American Physicians and fellowship in the AGA and American Association for the Advancement of Science.
DisclosuresDr. Turner is a founder and shareholder of Thelium Therapeutics and has served as a consultant for Entrinsic Biosciences, Immunic, and Kallyope.
Recent Contributions to PracticeUpdate:
- Number of Biopsies Required for Accurate Histological Assessment of Inflammation in Active Ulcerative Colitis
- Epithelial Neutropholic Infiltrates Are Independent Predictors for Long-Term Responses to Biologics in Ulcerative Colitis
- Novel Pathomechanism for Spontaneous Bacterial Peritonitis
- Not Ready for Prime Time: Real-Time Narrow-Band Imaging for Small Colorectal Polyps